Study-unit MOLECULAR BASES OF BIOTECHNOLOGICAL DRUGS
| Course name | Pharmacy |
|---|---|
| Study-unit Code | A000530 |
| Curriculum | Comune a tutti i curricula |
| Lecturer | Claudia Volpi |
| Lecturers |
|
| Hours |
|
| CFU | 6 |
| Course Regulation | Coorte 2020 |
| Supplied | 2023/24 |
| Supplied other course regulation | |
| Learning activities | Caratterizzante |
| Area | Discipline biologiche e farmacologiche |
| Sector | BIO/14 |
| Type of study-unit | Obbligatorio (Required) |
| Type of learning activities | Attività formativa monodisciplinare |
| Language of instruction | Italian |
| Contents | Study of the design, development, PK and PD features and therapeutic use of biodrugs |
| Reference texts | Vegeto, Maggi, Minghetti- Farmaci biotecnologici. CEA Teaching materials available in Unistudium |
| Educational objectives | The course of "Molecular basis of biodrugs activity " aims at giving to the students the skills to understand the differen steps of design, development and therapeutic use of the most important biodrugs |
| Prerequisites | Fundamentals of biology and pharmacology |
| Teaching methods | Theorical lessons |
| Other information | Attendance suggested |
| Learning verification modality | The acquisition of all the described skills will be verified by means of an oral examination. Oral test consists on an interview of about 30 minutes aiming to ascertain the knowledge and understanding level acquired by the student on theoretical contents as indicated on the program. |
| Extended program | Theory: . Definition and features of biodrugs . Biodrugs and innovative therapies . PK and PD of biodrugs . Clinical use of biodrugs |
| Obiettivi Agenda 2030 per lo sviluppo sostenibile | The course provides information to broaden one's knowledge in order to achieve goal 3 Health and well-being, in particular goal 3.b (Support the research and development of vaccines and drugs for communicable and non-communicable which mainly affect developing countries development, provide access to essential medicines and affordable vaccines accessible) |